Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2010
06/23/2010CN101156901B An externally used traditional Chinese medicine preparation for treating rheumatism and rheumatoid as well as its preparation method
06/23/2010CN101156862B A lecithin vitamine E mastication piece and method for making same
06/23/2010CN101152500B Chinese medicine for curing appendicitis and method for preparing the same
06/23/2010CN101152290B Externally used powder preparation stypticum
06/23/2010CN101152190B Orally disintegrating tablets of adefovir dipivoxil and method for preparing the same
06/23/2010CN101143177B Medicine for preventing and treating postpartum disease of cow
06/23/2010CN101138597B Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same
06/23/2010CN101129389B Suppository for treating colitis and method of preparing the same
06/23/2010CN101125187B Traditional Chinese medicinal plaster for treating pulmonary tuberculosis
06/23/2010CN101104015B Olive soft capsule raw material formulation and its preparation technology
06/23/2010CN101103998B External-applied medicinal powder for burn and scald and preparation method thereof
06/23/2010CN101099810B Pure traditional Chinese medicine preparation for treating acyesis and sterility
06/23/2010CN101077384B Application of traditional Chinese medicine preparation in preparing medicine for treating and preventing gynaecologic disease
06/23/2010CN101073643B Chinese-medicinal preparation for preventing and treating hypogalactias and and gynecopathy, its production and use
06/23/2010CN101062103B Olive soft capsule raw material formulation and its preparation technology
06/23/2010CN101060831B Conveniently implantable sustained release drug compositions
06/23/2010CN101053612B External applied traditional Chinese medicine vagina cleaning agent for curing gynecopathy and vagina cleaning ointment thereof
06/23/2010CN101053582B Method for applying complete puncturevine herb in preparing medicine for treating insulin resisting hyperglycemia and hypertension
06/23/2010CN101048135B Phenolic antiseptic compositions and methods of use
06/23/2010CN101036742B Medicine for treating prostatic disease
06/23/2010CN101020015B Externally applied medicine for treating chronic prostatitis and prostatic hyperplasia
06/23/2010CN101019895B Health product for reducing blood sugar and its prepn
06/23/2010CN101007113B Shenling Chinese medicine preparation for treating acute and chronic hepatitis and its preparation method
06/22/2010US7741476 contain low-molecular weight and high-molecular weight sodium hyaluronate; resistant to degradation
06/22/2010US7741474 Solubilising polysaccharides substituted with dydrophilic and hydrophobic groups
06/22/2010US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer'
06/22/2010US7741300 Methods of using nucleic acid vector-lipid complexes
06/22/2010US7741285 APO-2 ligand/trail formulations
06/22/2010US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein
06/22/2010US7741268 FDA Orange book listed patent for Follitropin alpha/beta a fertility drug; stable formulation, nonprecipitating, includes Pluronic F68 (aka Poloxamer 188), m-cresol as bacteriostat, diluent
06/22/2010US7740896 Precipitation occurs on substrate surfaces of oxides, nitrides, or carbides of metals and semiconductors, comprising use of water-soluble salts of compounds for treatment of these surfaces as sensor platforms, implants, medical devices
06/22/2010US7740884 Freeze-dried FSH/LH formulations
06/22/2010US7740883 reacting mono/di/tri or polycarboxylic acids (e.g.citric acid) with chitosan to form a first solution containing a chitosan nanoparticle that is partially crosslinked to form a core( amide linkage), forming shell on such core having free amino group on the surface with acrylic acid by amidation
06/22/2010US7740882 polyoxyethylene glycol having multiple functional groups, at least one of which is covalently bound to a therapeutic or diagnostic agent (peptide) , and a cell uptake promoter (formyl-met-leu-phe)covalently bound to the therapeutic or diagnostic agent; conjugates; pharmacokinetic; bioavailability
06/22/2010US7740881 Method of treating humans with opioid formulations having extended controlled release
06/22/2010US7740880 mixing a small interfering RNA with a conjugate comprising a cholesterol residue covalently bonded to oligoarginine through a formate residue linker, thereby forming the complex; carrier for delivery of an siRNA targeted to vascular endothelial growth factor for the treatment for cancer
06/22/2010US7740875 Organo-gel formulations for therapeutic applications
06/22/2010US7740874 A white petrolatum and a methyl glucose dioleate emulsifier selected for its hydrophilic-lipophilic balance, compatibility and as a neutral, nonionic absorption base whose use or permits low production temperatures; especially effective for a hydrocarotizone formulation; cosmetics; stabilizers-free
06/22/2010US7740861 extracted yeast cell wall comprising beta-glucan, a payload molecule(e.g.polynucleotides, polypeptides, proteins, and drugs) and a payload trapping molecule ( e.g polysaccharides, polyamides, polyacrylamide, cationic and anionic polymers, detergents); both in vivo/in vitro delivery of polyload molecule
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/22/2010US7740832 tacky, polymer is chosen from branched sulfonic polyester and (meth)acrylic ester polymers having with glass transition temperature (Tg) less than 20 degrees C.; for setting and/or maintaining hairstyle
06/22/2010US7740775 Method for the production of particles
06/22/2010US7740622 Elastomeric gloves and methods of making
06/22/2010US7740463 Pressurised metered dose inhalers (MDI)
06/22/2010CA2563325C Oral modified-release lozenges and their preparation method
06/22/2010CA2495875C Process for producing metered dose inhaler formulations
06/22/2010CA2479991C Process for production of crystals, crystals obtained thereby and their use in pharmaceutical preparations
06/22/2010CA2466868C Oral capsule formulation with increased physical stability
06/22/2010CA2461187C Lyophilized formulation
06/22/2010CA2442113C Prosthetic foot with tunable performance
06/22/2010CA2430829C Rapidly disintegrating tablet comprising an acid-labile active ingredient
06/22/2010CA2423094C Medical compositions, dressings and methods for treating microbial infections of skin lesions
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/22/2010CA2401593C Infusion packet with useful and decorative elements, support member, delivery system and method
06/17/2010WO2010068940A2 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy
06/17/2010WO2010068899A1 Nanoparticles comprising combinations of antiretroviral agents and use thereof
06/17/2010WO2010068866A2 Therapeutic particles suitable for parenteral administration and methods of making and using same
06/17/2010WO2010068864A2 Polyesters with grafted zwitterions
06/17/2010WO2010068827A1 Methods for enhancing stability of polyorthoesters and their formulations
06/17/2010WO2010068754A2 Methods and compositions for delivery of medicaments to the lungs
06/17/2010WO2010068705A2 Encapsulated agent guided imaging and therapies
06/17/2010WO2010068688A2 System and method for the delivery of a sanitizing foam
06/17/2010WO2010068654A1 Sustained release systems of ascorbic acid phosphate
06/17/2010WO2010068443A1 Stabilized nicotine chewing gum
06/17/2010WO2010068308A1 Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease
06/17/2010WO2010068281A2 Contact lens drug delivery device
06/17/2010WO2010068275A1 Silica-based antibacterial and antifungal nanoformulation
06/17/2010WO2010068255A1 Process of cracking biofeeds using high zeolite to matrix surface area catalysts
06/17/2010WO2010068130A1 Agent for treating oncological diseases using the isotope calcium-41
06/17/2010WO2010067869A1 Anti-viral agent and anti-viral composition
06/17/2010WO2010067617A1 Lipid membrane structure
06/17/2010WO2010067318A1 Compound, medicament, vaccine composition and nanocapsules
06/17/2010WO2010067199A2 Mixtures of plants in spagyric mother tincture for dry cough in babies
06/17/2010WO2010067151A1 Quick disintegrating taste masked composition
06/17/2010WO2010067140A1 Pulsed-release sildenafil composition and method for preparing said composition
06/17/2010WO2010067072A1 Rifaximin complexes
06/17/2010WO2010067035A1 Method for making a formulation and use thereof for administering polar drugs
06/17/2010WO2010066938A1 Use of nanoparticles as cytotoxic agents
06/17/2010WO2010066815A2 Encapsulating system for cest imaging with chelate q greater than or equal to 2
06/17/2010WO2010066749A2 Ulipristal acetate tablets
06/17/2010WO2010066687A2 Stabalized statin-comprising compositions
06/17/2010WO2010066613A1 Modified polyvinyllactams
06/17/2010WO2010066437A2 Aqueous composition containing dexpanthenol and sodium chloride
06/17/2010WO2010066385A1 Compacted moxifloxacin
06/17/2010WO2010066355A1 USE OF 17β-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVES FOR MANUFACTURING A MEDICAMENT IN A SUSTAINED-RELEASE FORM FOR PARENTERAL USE, AND SUSTAINED-RELEASE MEDICAMENT CONTAINING 17β-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVES FOR PARENTERAL USE
06/17/2010WO2010066354A1 USE OF 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVES FOR MANUFACTURING A MEDICAMENT IN A SUSTAINED-RELEASE FORM FOR PARENTERAL USE, AND SUSTAINED-RELEASE MEDICAMENT CONTAINING 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVES FOR PARENTERAL USE
06/17/2010WO2010066349A1 Use of 17beta-cyano-19-androst-4-ene derivatives for manufacturing a medicament in a sustained-release form for parenteral use, and sustained-release medicament containing 17beta-cyano-19-androst-4-ene derivatives for parenteral use
06/17/2010WO2010066342A1 Quetiapine composition
06/17/2010WO2010066268A1 Tamsulosin pellets for fixed dose combination
06/17/2010WO2010066203A1 Controlled releasing composition
06/17/2010WO2010066199A1 Use of racemates of pinocembrin in preparing medicaments for treating stroke
06/17/2010WO2010066159A1 A preparation method of venlafaxine sustained release formulation
06/17/2010WO2010066049A1 Methods and systems for inducing immunologic tolerance to non-self antigens
06/17/2010WO2010066047A1 Topical foaming composition and method of application
06/17/2010WO2010066034A1 Methadone formulation
06/17/2010WO2010041141A3 Oil-based foamable carriers and formulations
06/17/2010WO2010033598A3 System and method for utilizing microbubbles and liposomes as viral sequestering agents
06/17/2010WO2010033392A3 Methods and kits for treating cluster headache disorders
06/17/2010WO2010032113A3 Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin
1 ... 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 ... 2991